Achievement of international normalized ratio therapeutic range among chronic non-valvular atrial fibrillation patients treated with warfarin

被引：0
|
作者：
Harley, CR
Shetty, S
Hauch, O
Wygant, G
Riedel, AA
Nelson, M
机构：
[1] Ingenix, Eden Prairie, MN USA
[2] AstraZeneca LP, Wilmington, DE USA
来源：
CIRCULATION | 2004年 / 109卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P204
引用
收藏
页码：E271 / E271
页数：1
相关论文
共 50 条
  • [31] Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    Patel, Manesh R.
    HEART, 2016, 102 (13) : 1036 - 1043
  • [32] Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation
    Nelson, Winnie W.
    Milentijevic, Dejan
    Wang, Li
    Baser, Onur
    Damaraju, C. V.
    Schein, Jeffrey R.
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (08) : 899 - 906
  • [33] Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US
    Schoof, Nils
    Schnee, Janet
    Schneider, Gary
    Gawlik, Melissa
    Zint, Kristina
    Clemens, Andreas
    Bartels, Dorothee B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 795 - 804
  • [34] Under-use of warfarin for patients with non-valvular atrial fibrillation in Japan
    Inoue, H
    INTERNAL MEDICINE, 2004, 43 (07) : 529 - 530
  • [35] The Optimal Range of International Normalized Ratio for Radiofrequency Catheter Ablation of Atrial Fibrillation During Therapeutic Anticoagulation With Warfarin
    Kim, Jin-Seok
    Jongnarangsin, Krit
    Latchamsetty, Rakesh
    Chugh, Aman
    Ghanbari, Hamid
    Crawford, Thomas
    Yokokawa, Miki
    Good, Eric
    Bogun, Frank
    Pelosi, Frank, Jr.
    Morady, Fred
    Oral, Hakan
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02): : 302 - 309
  • [36] Clinical Profiles of Chronic Medication Use Among Patients With Non-Valvular Atrial Fibrillation
    Kocis, Paul T.
    Liu, Guodong
    Trocio, Jeffrey N.
    Makenbaeva, Dinara
    Baab, Kendall M.
    Trainer, JoAnn B.
    Abdulsattar, Younos
    Molina, Marta I.
    Leslie, Douglas L.
    CIRCULATION, 2014, 130
  • [37] Comparison of healthcare costs among patients with non-valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant
    Franchino-Elder, Jessica
    Gilligan, Adrienne
    Song, Xue
    Hartaigh, Briain O.
    Henriques, Caroline
    Sainski-Nguyen, Amy
    Wang, Cheng
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2020, 11 (02) : 133 - 140
  • [38] Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberte, Francois
    Pilon, Dominic
    Raut, Monika K.
    Nelson, Winnie W.
    Olson, William H.
    Germain, Guillaume
    Schein, Jeff R.
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1521 - 1528
  • [39] DEVELOPMENT OF A SHORT-TERM WARFARIN CONTROL MEASURE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Shi, L.
    Liu, S.
    Zhao, Y.
    Irimpen, A. K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 388 - 389
  • [40] HEALTH CARE UTILIZATION AND COSTS AFTER WARFARIN DISCONTINUATION AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (07) : A756 - A756
12345